Financial statements Pharmed Expert
Company suspended its operations from 2024-07-01
Balance sheet data of PHARMED EXPERT
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|---|
Total assets | 449 322,67 | 261 762,07 | 134 784,87 | 58 338,12 | 49 217,66 | 55 565,82 |
A. Fixed assets | 382 801,16 | 232 816,16 | 85 603,66 | 0,00 | 0,00 | 0,00 |
B. Current assets | 66 521,51 | 28 945,91 | 49 181,21 | 58 338,12 | 49 217,66 | 55 565,82 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Total liabilities | 449 322,67 | 261 762,07 | 134 784,87 | 58 338,12 | 49 217,66 | 55 565,82 |
A. Equity | -6 934,22 | -117 998,41 | -203 065,06 | -316 522,59 | -332 501,43 | -346 500,84 |
B. Liabilities and provisions for liabilities | 456 256,89 | 379 760,48 | 337 849,93 | 374 860,71 | 381 719,09 | 402 066,66 |
I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 195 359,31 |
II. Short-term liabilities | 228 490,25 | 241 234,96 | 286 915,88 | 374 860,71 | 381 719,09 | 206 707,35 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.